It was also shown in mice model of AD that transgenic animals overexpressing mutant form of human APP exhibited lower density of presynaptic terminals, as well as severe impairments in synaptic transmission in the hippocampus for months before the presence of amyloid plaques [65]. This evidence concerns the gene APP and Alzheimer disease.